PEO
Insurers Routinely Limit Addiction Treatment Authorizations. Employers Can Push Back.
By Anthony Beck, . Insurance Wire.
When an employee seeks treatment for substance use disorder, delays or interruptions in care can have serious consequences.
According to an October 29, 2026, report from Employee Benefit News, insurers commonly authorize addiction treatment in initial periods of four to seven days, requiring additional approval before treatment continues.
These short authorization periods do not necessarily mean treatment ends after a week. However, repeated reviews can create uncertainty for patients and treatment providers, particularly when additional coverage is denied or delayed.
For employers, the concern extends beyond healthcare costs. Interrupted treatment can affect employee recovery, attendance and the ability to return to work.
---
How Treatment Authorizations Work
Health insurers frequently use prior authorization and continuing medical necessity reviews to determine whether treatment qualifies for coverage.
An insurer may initially approve several days of inpatient or residential addiction treatment, then require updated clinical information before authorizing additional care.
The review process is intended to determine whether the patient continues to require that level of treatment.
Problems can arise when authorization decisions rely on restrictive criteria or fail to account for the patient's clinical condition.
A short initial authorization is not inherently inappropriate, but coverage decisions should reflect recognized clinical standards rather than arbitrary treatment durations.
Employers should understand which medical necessity criteria their health plans use and how disagreements between treatment providers and insurers are resolved.
---
Federal Mental Health Parity Requirements
The Mental Health Parity and Addiction Equity Act (MHPAEA) generally prohibits covered health plans from applying more restrictive treatment limitations to mental health and substance use disorder benefits than to comparable medical and surgical benefits.
These protections extend to certain nonquantitative treatment limitations, including prior authorization requirements, medical necessity criteria and continuing care reviews.
For example, a health plan that routinely authorizes shorter inpatient stays for substance use disorder treatment than for comparable medical care may raise concerns under federal parity requirements.
The Department of Labor identifies unusually frequent authorization reviews for mental health or addiction treatment as a potential warning sign of noncompliance.
Employers should understand that parity requirements apply to how restrictions are designed and administered, not simply whether addiction treatment appears among the plan's covered benefits.
---
What Employers Should Ask Their Insurers
Employers and benefits administrators can examine addiction treatment coverage during plan renewals and carrier evaluations.
Important questions include which clinical guidelines determine treatment eligibility, how frequently continuing authorization is required and whether the plan's review practices comply with federal parity requirements.
Employers should also examine access to inpatient, residential and outpatient treatment providers, along with procedures for expedited reviews and appeals.
For self-funded employers, there may be greater flexibility to negotiate certain administrative requirements with insurers or third-party administrators.
Employers purchasing fully insured coverage can still request explanations of authorization policies, review available carrier options and raise concerns about treatment restrictions.
Neither arrangement gives an employer unrestricted authority to override individual medical necessity decisions.
---
What This Means for Employers Using a PEO
Professional Employer Organizations (PEOs) may provide access to group health insurance programs, but participating employers generally have less direct control over the underlying plan design and carrier authorization policies.
A PEO client concerned about addiction treatment coverage should ask the PEO's benefits team which clinical criteria the carrier uses, what treatment facilities are available and how employees can appeal denied authorizations.
PEOs can also raise recurring access concerns with their insurance carriers and benefits administrators.
For businesses comparing PEO health plans, treatment access and authorization practices deserve consideration alongside premiums, deductibles and provider networks.
---
Why Authorization Practices Matter
The Employee Benefit News report highlights a potential gap between the treatment employees need and the coverage insurers initially authorize.
The reported four-to-seven-day authorization period does not establish how frequently treatment is ultimately denied or prematurely discontinued.
Nevertheless, employers have reason to review whether their plans support appropriate continuation of care and provide effective appeal procedures.
A health plan's value depends not only on which treatments are covered, but also on whether employees can access medically necessary care when they need it.
---
Sources
Employee Benefit News — What Employers Should Ask Insurers About Addiction Treatment Coverage https://www.benefitnews.com/news/Addiction-Treatment-Coverage-What-Employers-Should-Ask
U.S. Department of Labor — Mental Health and Substance Use Disorder Parity https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-and-substance-use-disorder-parity
U.S. Department of Labor — Understanding Your Mental Health and Substance Use Disorder Benefits https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/resource-center/publications/understanding-your-mental-health-and-substance-use-disorder-benefits
Insurance Wire provides news and information, not insurance, legal, or financial advice. Consult a qualified professional about your specific needs.